Mobia Medical (MOBI) Director Myriam Curet Receives Awards

What Happened
Myriam Curet, a director of Mobia Medical, received two derivative awards (stock option grants) on July 30, 2026: 19,740 options and 15,960 options, for a total of 35,700 options. The grants were reported as acquisitions at $0.00 per share (no cash paid). These are compensation awards rather than open-market purchases or sales.

Key Details

• Transaction date: 2026-07-30; Form 4 filed: 2026-08-03 (filing appears timely under the two-business-day rule).
• Instruments: Derivative securities (stock options) shown as "A" = Award/Grant.
• Counts and prices: 19,740 options @ $0.00 and 15,960 options @ $0.00 (total 35,700).
• Cash paid: $0 reported (these are grant awards, not purchases).
• Shares owned after transaction: not specified in the filing.
• Footnotes:
  • F1 – One option grant vests in three substantially equal installments on each of the first three anniversaries of the grant date.
  • F2 – The other option grant will fully vest at the 2027 Annual Meeting, per the Non-Employee Director Compensation Policy.

Context
These entries represent compensation-related option grants to a non-employee director. As derivative awards, they give the right to acquire shares in the future according to the vesting schedules above; they are not immediate stock purchases or sales. Such director awards are commonly part of routine compensation and do not, by themselves, indicate a buying or selling signal.